Showing results (111-120 of 161) with videos related to
Sort By:
Pageof 17
Neurourology and Urodynamics|September 7, 2022
Effect of LHRH analogs on lower urinary tract symptoms associated with advanced prostate cancer in real clinical practice: ANALUTS studyJuan Morote, Antonio Gómez-Caamaño, Raúl Poza de Celis, et al.Cancers|October 27, 2022
A Clinically Significant Prostate Cancer Predictive Model Using Digital Rectal Examination Prostate Volume Category to Stratify Initial Prostate Cancer Suspicion and Reduce Magnetic Resonance Imaging DemandJuan Morote, Ángel Borque-Fernando, Marina Triquell, et al.Archivos Espanoles De Urologia|July 3, 2008
[Laparoscopic radical cystectomy in clinically localized (T2) bladder tumors]Lluís Cecchini Rosell, Anna Orsola los de Santos, Carles X Raventós Busquets, et al.European Urology Open Science|July 11, 2024
Evaluating the Quality of Local Programs for Early Detection of Significant Prostate CancerJuan Morote, Nahuel Paesano, Natàlia Picola, et al.The Journal of Urology|May 11, 2017
Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic ImplicationsStephanie A M Wankowicz, Lillian Werner, Anna Orsola, et al.International Journal of Radiation Oncology, Biology, Physics|June 6, 2017
Cognitive Function in Patients With Prostate Cancer Receiving Luteinizing Hormone-Releasing Hormone Analogues: A Prospective, Observational, Multicenter StudyJuan Morote, Ángel José Tabernero, José Luis Álvarez Ossorio, et al.International Journal of Molecular Sciences|June 19, 2013
The present and future of prostate cancer urine biomarkersMarina Rigau, Mireia Olivan, Marta Garcia, et al.The World Journal of Men'S Health|January 2, 2024
The Role of Digital Rectal Examination Prostate Volume Category in the Early Detection of Prostate Cancer: Its Correlation with the Magnetic Resonance Imaging Prostate VolumeJuan Morote, Natàlia Picola, Jesús Muñoz-Rodriguez, et al.Cancers|September 28, 2023
A Diagnostic Accuracy Study of Targeted and Systematic Biopsies to Detect Clinically Significant Prostate Cancer, including a Model for the Partial Omission of Systematic BiopsiesJuan Morote, Natàlia Picola, Jesús Muñoz-Rodriguez, et al.Urologic Oncology|May 27, 2023
Are magnetic resonance imaging and targeted biopsies needed in men with serum prostate-specific antigen over 10 ng/ml and an abnormal digital rectal examination?Juan Morote, Natàlia Picola, Nahuel Paesano, et al.Pageof 17